AZN

AstraZeneca PLC (AZN) P/E Ratio
P/E Ratio as of Oct 29, 2026: 25.88
Average24.35
Median24.19
Minimum23.13
Maximum25.88
25.88
1.51 (6.20%)past month
The P/E ratio for AstraZeneca PLC (AZN) is 25.88 as of Oct 29, 2026. This represents a decrease of -27.12% compared to its 12-month average P/E ratio of 35.51. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
AstraZeneca PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
AstraZeneca PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing AstraZeneca PLC to industry peers.
AstraZeneca PLC P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
AstraZeneca PLC’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing AstraZeneca PLC to industry peers.
AstraZeneca PLC (AZN) P/E Ratio Insights
See AstraZeneca PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AstraZeneca PLC (AZN)
Order type
Buy in
Order amount
Est. shares
0 shares
AstraZeneca PLC (AZN) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $157.70 | 23.41 |
| Sep 1, 2026 | $162.47 | 24.11 |
| Aug 3, 2026 | $157.97 | 23.45 |
| Jul 1, 2026 | $183.86 | 27.43 |
| Jun 1, 2026 | $179.71 | 26.81 |
| May 1, 2026 | $184.74 | 27.57 |
| Apr 1, 2026 | $200.73 | 30.44 |
| Mar 2, 2026 | $203.73 | 30.89 |
| Feb 2, 2026 | $188.41 | 31.08 |
| Jan 2, 2026 | $183.14 | 60.34 |
AstraZeneca PLC (AZN) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | 25.88 | -57.28% |
| 2025 | 60.58 | -3.12% |
| 2024 | 62.53 | -11.67% |
| 2023 | 70.79 | -65.63% |
| 2022 | 205.95 | -75.22% |
| 2021 | 830.96 | — |
FAQs About AstraZeneca PLC (AZN) P/E ratio
The latest P/E ratio of AstraZeneca PLC (AZN) is 25.88, as of Oct 29, 2026. This is calculated based on its current stock price and earnings per share (EPS).
AstraZeneca PLC’s last 12-month average P/E ratio is 35.51, compared to its current P/E ratio of 25.88. This reflects a decrease of -27.12%.
AstraZeneca PLC’s current P/E ratio of 25.88 is lower than its last 12-month average P/E of 35.51. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
AstraZeneca PLC’s average P/E ratio over the last 3 years is 56.49. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
AstraZeneca PLC’s average P/E ratio over the last 5 years is 71.7. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
AstraZeneca PLC (AZN) P/E Ratio Insights
See AstraZeneca PLC’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in AstraZeneca PLC (AZN)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.